Eastman Chemical (NYSE:EMN - Free Report) - Stock analysts at Zacks Research cut their Q2 2025 earnings estimates for shares of Eastman Chemical in a research note issued to investors on Wednesday, May 7th. Zacks Research analyst R. Department now expects that the basic materials company will post earnings per share of $1.86 for the quarter, down from their prior estimate of $2.19. The consensus estimate for Eastman Chemical's current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical's Q3 2025 earnings at $1.90 EPS, FY2025 earnings at $7.42 EPS, Q2 2026 earnings at $1.92 EPS, Q3 2026 earnings at $2.08 EPS, FY2026 earnings at $8.03 EPS and FY2027 earnings at $8.88 EPS.
A number of other analysts have also issued reports on EMN. Morgan Stanley lowered their price target on Eastman Chemical from $125.00 to $115.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Barclays dropped their price target on shares of Eastman Chemical from $108.00 to $85.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 29th. Royal Bank of Canada raised shares of Eastman Chemical from a "sector perform" rating to an "outperform" rating and set a $91.00 price target on the stock in a research report on Wednesday, April 9th. Piper Sandler reduced their price target on Eastman Chemical from $105.00 to $99.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. Finally, StockNews.com lowered Eastman Chemical from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $99.15.
Check Out Our Latest Analysis on EMN
Eastman Chemical Stock Performance
Eastman Chemical stock traded down $0.38 during mid-day trading on Monday, hitting $82.39. The company had a trading volume of 2,018,704 shares, compared to its average volume of 1,063,846. The company's fifty day moving average is $82.55 and its 200-day moving average is $92.41. Eastman Chemical has a 12-month low of $70.90 and a 12-month high of $114.50. The company has a market capitalization of $9.51 billion, a price-to-earnings ratio of 10.73, a P/E/G ratio of 1.22 and a beta of 1.29. The company has a current ratio of 1.51, a quick ratio of 0.78 and a debt-to-equity ratio of 0.78.
Eastman Chemical (NYSE:EMN - Get Free Report) last issued its earnings results on Thursday, April 24th. The basic materials company reported $1.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.89 by $0.02. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%. The company had revenue of $2.29 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the business posted $1.61 EPS. The firm's quarterly revenue was down .9% on a year-over-year basis.
Eastman Chemical Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 8th. Investors of record on Friday, June 13th will be paid a $0.83 dividend. This represents a $3.32 annualized dividend and a dividend yield of 4.03%. The ex-dividend date is Friday, June 13th. Eastman Chemical's payout ratio is presently 42.24%.
Hedge Funds Weigh In On Eastman Chemical
Hedge funds and other institutional investors have recently modified their holdings of the stock. Barclays PLC grew its position in shares of Eastman Chemical by 3.5% in the 3rd quarter. Barclays PLC now owns 315,044 shares of the basic materials company's stock valued at $35,268,000 after purchasing an additional 10,695 shares during the period. Principal Financial Group Inc. grew its position in shares of Eastman Chemical by 6.8% during the 3rd quarter. Principal Financial Group Inc. now owns 148,176 shares of the basic materials company's stock worth $16,588,000 after purchasing an additional 9,447 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Eastman Chemical by 5.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,140 shares of the basic materials company's stock worth $1,383,000 after purchasing an additional 777 shares during the period. Czech National Bank increased its stake in shares of Eastman Chemical by 5.5% in the 4th quarter. Czech National Bank now owns 25,133 shares of the basic materials company's stock valued at $2,295,000 after purchasing an additional 1,320 shares during the last quarter. Finally, Cooper Financial Group grew its stake in shares of Eastman Chemical by 7.4% during the fourth quarter. Cooper Financial Group now owns 3,725 shares of the basic materials company's stock worth $340,000 after buying an additional 256 shares during the last quarter. Institutional investors own 83.65% of the company's stock.
Eastman Chemical Company Profile
(
Get Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Featured Stories

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.